[Neoadjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Moro
D
D
Unité d'oncologie thoracique, CHU, Grenoble.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D015337:Multicenter Studies as Topic; D020360:Neoadjuvant Therapy; D011182:Postoperative Care; D011879:Radiotherapy Dosage; D013997:Time Factors
D000970:Antineoplastic Agents
Traitement néo-adjuvant pour les stades précoces des cancers bronchiques non à petites cellules (CBNPC).